Hikal
HIKAL.NSHIKAL.NS · Stock Price
Historical price data
Overview
Hikal's mission is to be the preferred global partner for complex chemical synthesis and manufacturing in pharmaceuticals and crop protection. The company has achieved this through consistent investment in advanced technology platforms, building long-term relationships with multinational clients, and establishing a reputation for quality and reliability. Its strategy focuses on deepening capabilities in high-value segments like HPAPIs, expanding its service offerings in drug discovery support, and capitalizing on the global outsourcing trend. With a strong financial position as a publicly listed entity, Hikal is well-positioned for sustained growth.
Technology Platform
Hikal's platform is centered on advanced chemical synthesis, including hazardous chemistry, cryogenics, continuous flow, and high-potency API (HPAPI) manufacturing, supported by robust process research and development (PR&D) for scalable, cost-effective production.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Hikal competes with large global CDMOs (e.g., Lonza, Catalent), other major Indian CDMOs (e.g., Divi's Labs, Laurus Labs), and cost-aggressive Chinese players (e.g., WuXi). Its differentiation lies in deep expertise in niche, complex chemical synthesis and a strong reputation for quality and IP protection.
